tradingkey.logo

Rapid Micro Biosystems Inc <RPID.OQ> expected to post a loss of 23 cents a share - Earnings Preview

ReutersFeb 26, 2025 1:47 PM
  • Rapid Micro Biosystems Inc RPID.OQ RPID.O is expected to show a rise in quarterly revenue when it reports results on February 28 for the period ending December 31 2024

  • The Lexington Massachusetts-based company is expected to report a 23.1% increase in revenue to $7.8 million from $6.34 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.

  • ​LSEG's mean analyst estimate for Rapid Micro Biosystems Inc is for a loss of 23 cents per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Rapid Micro Biosystems Inc is $8.00​, above​ its last closing price of $2.82. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Sep. 30 2024

-0.25

-0.26

Missed

-2

Jun. 30 2024

-0.28

-0.28

-0.29

Missed

-4.8

Mar. 31 2024

-0.29

-0.29

-0.31

Missed

-6.9​

Dec. 31 2023

-0.30

-0.30

-0.26

Beat

13.3

​​Sep. 30 2023

-0.30

-0.31

-0.31

Met

-1.1

Jun. 30 2023

-0.35

-0.35

-0.33

Beat

5.7​

Mar. 31 2023

-0.37

-0.36

-0.32

Beat

12.3

Dec. 31 2022

-0.34

-0.36

-0.39

Missed

-8.3

This summary was machine generated February 26 at 13:47 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI